Is blood transfusion therapy the ideal treatment for ?-Thalassemia Intermedia?
The thalassemias represent the most common single gene disorder worldwide. The total annual incidence of symptomatic individuals with ?-thalassemia is estimated at 1 in 100,000 throughout the world (1) of which nearly 10% have ?-thalassemia intermedia (TI) (2). Several approaches have been used for...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
PAGEPress Publications
2014-08-01
|
| Edice: | Mediterranean Journal of Hematology and Infectious Diseases |
| Témata: | |
| On-line přístup: | https://mjhid.org/index.php/mjhid/article/view/1685 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|